- Indian Government Tightens Surveillance On GLP-1 Weight-Loss Drugs As Generics Flood Market After Semaglutide Patent Expiry Swarajyamag
- Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details The Times of India
- GLP-1 Should Not Be Used As A Quick Fix For Weight Loss And Diabetes Management, Warns Top Experts NDTV
- ‘Clinical oversight can lead to…’: Govt lists side-effects that can occur from weight-loss drugs Business Today
- Weight-loss drug buzz grows but are ‘awareness’ ads crossing the line? The Indian Express
1 views
Indian Government Tightens Surveillance On GLP-1 Weight-Loss Drugs As Generics Flood Market After Semaglutide Patent Expiry - Swarajyamag
Indian Government Tightens Surveillance On GLP-1 Weight-Loss Drugs As Generics Flood Market After Semaglutide Patent Expiry Swarajyamag Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key…
